Eris Lifesciences Acquires Branded Probiotic Products from Velbiom Probiotics
Eris Lifesciences Limited announced Friday, March 20, 2026, the execution of a Business Transfer Agreement (BTA) with Velbiom Probiotics Private Limited (VPPL) for the acquisition of its Branded Probiotic Products on a slump sale basis.Velbiom is a bio-therapeutics company focused on microbiome-based therapy and research. The acquired portfolio includes formulations of prebiotics and probiotics for metabolic health, gut wellness and women's health.
The consideration for the acquisition is 50 crore Indian Rupees.
According to financial data, the revenue of the acquired probiotics business over the past three years was:
| Financial Year | Revenue (Rs. Crore) |
|---|---|
| FY26 (9 months) | 16.02 |
| FY25 | 19.64 |
| FY24 | 17.56 |
The Board of Directors of Eris Lifesciences met between 12:45 P.M. and 03:15 P.M. to approve the BTA and related documents. Neither company holds a significant shareholding in the other, and the transaction is not considered a related party transaction.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Last edited by a moderator: